Acarix AB (publ) publishes Year-End Report 2021
Press release Malmö, Sweden, February 17, 2022 Acarix AB (publ) publishes Year-End Report 2021 Groundwork laid for accelerated expansion in the USDuring the fourth quarter, we presented the operational
Stay updated with breaking news from Acarix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release Malmö, Sweden, February 17, 2022 Acarix AB (publ) publishes Year-End Report 2021 Groundwork laid for accelerated expansion in the USDuring the fourth quarter, we presented the operational
Press release Malmö, Sweden, February 17, 2022 Groundwork laid for accelerated expansion in the USDuring the fourth quarter, we presented the operational and financial goals based on our three-year
Press release Malmö, Sweden, February 9, 2022 Acarix AB (publ) brings forward publication of interim report for fourth quarter to February 17, 2022 Acarix AB has decided to bring forward
Press release Malmö, Sweden, February 9, 2022 Acarix submits breakthrough designation request with FDA for heart failure diagnosis Acarix expands its portfolio and submits a breakthrough designation
Trading in Acarix AB's paid subscription shares is to cease. The last trading day is January 11, 2022. Short name: ACARIX BTA --------------------------- ISIN code: SE0017132400 --------------------------- Orderbook